# Pentadeca Arginate (PDA)

Canonical source: https://retacompare.com/encyclopedia/pentadeca-arginate

Same as BPC-157 — angiogenesis, growth-factor modulation, tendon/GI healing in animal models.

Reference facts

Also known asBPC-157 Arginate Salt, PDACategoryHealing & Tissue RepairMechanism of actionSame as BPC-157 — angiogenesis, growth-factor modulation, tendon/GI healing in animal models.TargetsSame as BPC-157Indications under research or approvedResearch onlyRegulatory status (reference entry)Not FDA-approved; same regulatory status as BPC-157Half-lifeComparable to BPC-157 acetateSequenceGEPPPGKPADDAGLVSequence notesBPC-157 backbone (15-residue, 'pentadeca') as the arginate salt — promoted as more stable in solution than the acetate.Molecular weight (Da)1419First reported2023
    Primary References

Sikiric et al., Curr Pharm Des 2014


    Explore research articles about Pentadeca Arginate (PDA)


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Sikiric et al., Curr Pharm Des 2014: https://pubmed.ncbi.nlm.nih.gov/23092289/